Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015)

Bausch Health Companies (BHC) reported Curent Deferred Tax Liability of $11.6 million for Q3 2015, down 38.95% on a YoY basis from $19.0 million in Q3 2014, and down 69.63% sequentially from $38.2 million in Q2 2015.

Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015) Analysis & Trends

Bausch Health Companies (BHC) has 6 years of Curent Deferred Tax Liability data on file, last reported at $11.6 million in Q3 2015.

  • For the quarter ending Q3 2015, Curent Deferred Tax Liability fell 38.95% year-over-year to $11.6 million; the trailing twelve-month figure through Sep 2015 stood at $11.6 million (down 38.95% YoY), and the FY2014 full-year result was $10.7 million, down 83.79% from the prior year.
  • Curent Deferred Tax Liability eased to $11.6 million in Q3 2015, from $38.2 million in the prior quarter.
  • In the past five years, Curent Deferred Tax Liability ranged from a high of $66.0 million in Q4 2013 to a low of $1.9 million in Q1 2011.
  • A 5-year average of $15.5 million and a median of $8.2 million in 2012 frame the typical range for Curent Deferred Tax Liability.
  • Across the five-year window, Curent Deferred Tax Liability soared 1398.98% in 2013 and plunged 83.79% in 2014, its largest moves.
  • Tracing BHC's Curent Deferred Tax Liability over 5 years: stood at $4.4 million in 2011, then decreased by 0.79% to $4.4 million in 2012, then soared by 1398.98% to $66.0 million in 2013, then sank by 83.79% to $10.7 million in 2014, then advanced by 8.41% to $11.6 million in 2015.
  • Business Quant data shows BHC's Curent Deferred Tax Liability at $11.6 million in Q3 2015, $38.2 million in Q2 2015, and $10.7 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2015 11.60 Mn
Sep 30, 2015 11.60 Mn
Jun 30, 2015 38.20 Mn
Jun 30, 2015 38.20 Mn
Dec 31, 2014 10.70 Mn
Dec 31, 2014 10.70 Mn
Sep 30, 2014 19.00 Mn
Sep 30, 2014 19.00 Mn
Jun 30, 2014 11.00 Mn
Jun 30, 2014 11.00 Mn
Mar 31, 2014 10.80 Mn
Mar 31, 2014 10.80 Mn
Dec 31, 2013 66.00 Mn
Dec 31, 2013 66.00 Mn
Sep 30, 2013 64.19 Mn
Sep 30, 2013 64.19 Mn
Jun 30, 2013 4.36 Mn
Jun 30, 2013 4.36 Mn
Mar 31, 2013 4.29 Mn
Mar 31, 2013 4.29 Mn